Globally, prescription drug sales grew 6.1% between 2006 and 2007. In the U.S., Rx sales grew 3.8% in the same period. This is the weakest U.S. sales rate for prescription drugs since 1996. These stats come to you from IMSHealth, whose annual U.S. Pharmaceutical Market Performance Review found over a 50% drop in Rx [...]
Archive | Bio/life sciences RSS feed for this section
Corporate reputation: pharma, gas and finance tie for the penultimate position
The reputation of the pharma industry continues to lag behind other consumer-facing businesses, based on Harris Interactive’s latest survey into corporate reputations. The 9th annual Reputation Quotient survey is out. Technology is king; other industries, like airlines, consumer products, insurance/financial services, pharmaceutical and retail – have plummeted over the past two years, according to Harris [...]
Happy Birthday, Viagra
It’s the drug that raised the profile of medicine in popular culture. It’s been hawked by a prominent politician and has been the butt of jokes on late-night TV. It’s Viagra, and it’s turning 10 today. The FDA approved the drug on March 27, 1998. Here is the FDA’s approval page for it. Pfizer‘s [...]
The golden era of generic drugs
This is how IMS recently referred to 2008 and the next phase of the pharmaceutical drug market. I recently posted here a pharma market update on drug prices (up), DTC (working), and generics (“the un-detail”). Here’s the PS for that post, brought to you from IMS, the prominent market research firm focused on [...]
Wal-Mart’s leading role in health care — now, as PBM
When the health care Oscars are announced in 2010 for top roles, the health care academy won’t know whether to cast Wal-Mart as the lead, supporting, director, or producer in health care. Wal-Mart is the third largest pharmacy chain in the U.S. As #1 on the Fortune 500 list, the retailer’s role as a jumbo [...]
About Jane & Health Populi
Jane Sarasohn-Kahn is a health economist and management consultant that serves clients at the intersection of health and technology.
Her clients include all stakeholders in health, including providers, payors and plans; companies in biopharma, medical devices, financial services, technology and consumer goods; non-profits and NGOs. Jane's lens on health is best-defined by the World Health Organization: health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.
-
ePatients: a connected, collaborative, creating community
-
Patients want online communication with doctors, and more clinicians are listening
-
Meeker & Murphy on Mobile – through the lens of health
-
Patient Power Through Data Liberación, and Private Sector to the Rescue – Health 2.0 DC Takeaways
